Prognostic significance of HER2 status evaluation using immunohistochemistry in patients with urothelial carcinoma of the bladder: A retrospective single‑center experience

In recent years, antibody-drug conjugate (ADC) therapy targeting human epidermal growth factor receptor 2 (HER2) has been proven to be beneficial in patients with advanced urothelial carcinoma of the bladder (UCB); however, the role of HER2 in UCB remains obscure. Thus, the present retrospective sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xuesong, He, Weiyang, Yin, Hubin, Li, Xinyuan, Zhou, Xiang, Wei, Zongjie, Yu, Haitao, Gou, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622977/
https://www.ncbi.nlm.nih.gov/pubmed/36324611
http://dx.doi.org/10.3892/etm.2022.11640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622977/
https://www.ncbi.nlm.nih.gov/pubmed/36324611
http://dx.doi.org/10.3892/etm.2022.11640

Ejemplares similares